Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00DQZ
|
|||
Former ID |
DNC013518
|
|||
Drug Name |
S-2,9-dioxo-9-(phenylamino)nonyl ethanethioate
|
|||
Synonyms |
CHEMBL272613
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H23NO3S
|
|||
Canonical SMILES |
CC(=O)SCC(=O)CCCCCCC(=O)NC1=CC=CC=C1
|
|||
InChI |
1S/C17H23NO3S/c1-14(19)22-13-16(20)11-7-2-3-8-12-17(21)18-15-9-5-4-6-10-15/h4-6,9-10H,2-3,7-8,11-13H2,1H3,(H,18,21)
|
|||
InChIKey |
OCDCFMXSXAYLLI-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Histone deacetylase 8 (HDAC8) | Target Info | Inhibitor | [1] |
KEGG Pathway | Alcoholism | |||
Viral carcinogenesis | ||||
Panther Pathway | Wnt signaling pathway | |||
Pathway Interaction Database | Signaling events mediated by HDAC Class I | |||
Reactome | NOTCH1 Intracellular Domain Regulates Transcription | |||
Constitutive Signaling by NOTCH1 PEST Domain Mutants | ||||
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | ||||
HDACs deacetylate histones | ||||
WikiPathways | Integrated Pancreatic Cancer Pathway | |||
Neural Crest Differentiation | ||||
Cell Cycle |
References | Top | |||
---|---|---|---|---|
REF 1 | Histone deacetylase inhibitors: from bench to clinic. J Med Chem. 2008 Mar 27;51(6):1505-29. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.